TY - JOUR
T1 - Comparison of flow diversion and coiling in large unruptured intracranial saccular aneurysms
AU - Chalouhi, Nohra
AU - Tjoumakaris, Stavropoula
AU - Starke, Robert M.
AU - Gonzalez, L. Fernando
AU - Randazzo, Ciro
AU - Hasan, David
AU - McMahon, Jeffrey F.
AU - Singhal, Saurabh
AU - Moukarzel, Lea A.
AU - Dumont, Aaron S.
AU - Rosenwasser, Robert
AU - Jabbour, Pascal
PY - 2013/8
Y1 - 2013/8
N2 - BACKGROUND AND PURPOSE-: Flow diversion has emerged as an important tool for the management of intracranial aneurysms. The purpose of this study was to compare flow diversion and traditional embolization strategies in terms of safety, efficacy, and clinical outcomes in patients with unruptured, large saccular aneurysms (≥10 mm). METHODS-: Forty patients treated with the Pipeline Embolization Device (PED) were matched in a 1:3 fashion with 120 patients treated with coiling based on patient age and aneurysm size. Fusiform and anterior communicating artery aneurysms were eliminated from the analysis. Procedural complications, angiographic results, and clinical outcomes were analyzed and compared. RESULTS-: There were no differences between the 2 groups in terms of patient age, sex, aneurysm size, and aneurysm location. The rate of procedure-related complications did not differ between the PED (7.5%) and the coil group (7.5%; P=1). At the latest follow-up, a significantly higher proportion of aneurysms treated with PED (86%) achieved complete obliteration compared with coiled aneurysms (41%; P<0.001). In multivariable analysis, coiling was an independent predictor of nonocclusion. Retreatment was necessary in fewer patients in the PED group (2.8%) than the coil group (37%; P<0.001). A similar proportion of patients attained a favorable outcome (modified Rankin Scale, 0-2) in the PED group (92%) and in the coil group (94%; P=0.8). CONCLUSIONS-: The PED provides higher aneurysm occlusion rates than coiling, with no additional morbidity and similar clinical outcomes. These findings suggest that the PED might be a preferred treatment option for large unruptured saccular aneurysms.
AB - BACKGROUND AND PURPOSE-: Flow diversion has emerged as an important tool for the management of intracranial aneurysms. The purpose of this study was to compare flow diversion and traditional embolization strategies in terms of safety, efficacy, and clinical outcomes in patients with unruptured, large saccular aneurysms (≥10 mm). METHODS-: Forty patients treated with the Pipeline Embolization Device (PED) were matched in a 1:3 fashion with 120 patients treated with coiling based on patient age and aneurysm size. Fusiform and anterior communicating artery aneurysms were eliminated from the analysis. Procedural complications, angiographic results, and clinical outcomes were analyzed and compared. RESULTS-: There were no differences between the 2 groups in terms of patient age, sex, aneurysm size, and aneurysm location. The rate of procedure-related complications did not differ between the PED (7.5%) and the coil group (7.5%; P=1). At the latest follow-up, a significantly higher proportion of aneurysms treated with PED (86%) achieved complete obliteration compared with coiled aneurysms (41%; P<0.001). In multivariable analysis, coiling was an independent predictor of nonocclusion. Retreatment was necessary in fewer patients in the PED group (2.8%) than the coil group (37%; P<0.001). A similar proportion of patients attained a favorable outcome (modified Rankin Scale, 0-2) in the PED group (92%) and in the coil group (94%; P=0.8). CONCLUSIONS-: The PED provides higher aneurysm occlusion rates than coiling, with no additional morbidity and similar clinical outcomes. These findings suggest that the PED might be a preferred treatment option for large unruptured saccular aneurysms.
KW - aneurysm
KW - coils
KW - flow diverter
KW - pipeline embolization device
UR - http://www.scopus.com/inward/record.url?scp=84880844857&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880844857&partnerID=8YFLogxK
U2 - 10.1161/STROKEAHA.113.001785
DO - 10.1161/STROKEAHA.113.001785
M3 - Article
C2 - 23723311
AN - SCOPUS:84880844857
SN - 0039-2499
VL - 44
SP - 2150
EP - 2154
JO - Stroke
JF - Stroke
IS - 8
ER -